Trials / Completed
CompletedNCT02820597
ClariFix Cryoablation Clinical Study
Clinical Evaluation of Cryotherapy in the Nasal Passageway Using the ClariFix Device
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Arrinex, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm pilot study designed to evaluate the feasibility of cryoablation in the nasal passageway, using the ClariFix device, to reduce the symptoms of chronic rhinitis.
Detailed description
This is a small, prospective, multicenter, single-arm, self-controlled interventional feasibility study to evaluation cryoablation in the nasal passage as a treatment for chronic rhinitis. The ClariFix device is FDA-cleared device with the intended use for the destruction of unwanted tissue during surgical procedures, including in adults with chronic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ClariFix device |
Timeline
- Start date
- 2015-06-15
- Primary completion
- 2016-02-05
- Completion
- 2016-07-20
- First posted
- 2016-07-01
- Last updated
- 2019-10-21
- Results posted
- 2019-10-21
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02820597. Inclusion in this directory is not an endorsement.